DESOWEN Drug Patent Profile
✉ Email this page to a colleague
When do Desowen patents expire, and when can generic versions of Desowen launch?
Desowen is a drug marketed by Galderma Labs Lp and is included in three NDAs.
The generic ingredient in DESOWEN is desonide. There are thirty-one drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Desowen
A generic version of DESOWEN was approved as desonide by TARO on August 3rd, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DESOWEN?
- What are the global sales for DESOWEN?
- What is Average Wholesale Price for DESOWEN?
Summary for DESOWEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 60 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,822 |
| DailyMed Link: | DESOWEN at DailyMed |
Recent Clinical Trials for DESOWEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Procter and Gamble | Phase 3 |
Pharmacology for DESOWEN
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for DESOWEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | DESOWEN | desonide | CREAM;TOPICAL | 019048-001 | Dec 14, 1984 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Galderma Labs Lp | DESOWEN | desonide | LOTION;TOPICAL | 072354-001 | Jan 24, 1992 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Galderma Labs Lp | DESOWEN | desonide | OINTMENT;TOPICAL | 071425-001 | Jun 15, 1988 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
